Lineage Cell Therapeutics
LCTX
#8800
Rank
HK$0.85 B
Marketcap
HK$3.90
Share price
0.93%
Change (1 day)
-52.88%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Cash on Hand

Cash on Hand as of September 2024 : HK$0.25 Billion

According to Lineage Cell Therapeutics 's latest financial reports the company has HK$0.25 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lineage Cell Therapeutics - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$0.27 B-38.7%
2022-12-31HK$0.45 B-0.63%
2021-12-31HK$0.45 B41.23%
2020-12-31HK$0.32 B34.69%
2019-12-31HK$0.23 B-0.63%
2018-12-31HK$0.24 B-19.29%
2017-12-31HK$0.29 B69.33%
2016-12-31HK$0.17 B-47.13%
2015-12-31HK$0.33 B45.64%
2014-12-31HK$0.22 B436.77%
2013-12-31HK$42.61 M26.39%
2012-12-31HK$33.71 M-80.46%
2011-12-31HK$0.17 B-33.48%
2010-12-31HK$0.25 B174.4%
2009-12-31HK$94.51 M99504.27%
2008-12-31HK$0.09 M28.09%
2007-12-31HK$0.07 M-98.3%
2006-12-31HK$4.36 M-69.31%
2005-12-31HK$14.21 M33.47%
2004-12-31HK$10.65 M91.62%
2003-12-31HK$5.55 M-44.5%
2002-12-31HK$10.01 M-22.28%
2001-12-31HK$12.88 M25.34%
2000-12-31HK$10.28 M-74.99%
1999-12-31HK$41.11 M121.14%
1998-12-31HK$18.59 M
1998-06-30HK$31.76 M-47.43%
1997-06-30HK$60.43 M225.28%
1996-06-30HK$18.57 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$2.11 B 732.65%๐Ÿ‡บ๐Ÿ‡ธ USA